Your Coronavirus Test Is Positive. Maybe It Shouldn’t Be.

THE NEW YORK TIMES - Some of the nation’s leading public health experts are raising a new concern in the endless debate over coronavirus testing in the United States: The standard tests are diagnosing huge numbers of people who may be carrying relatively insignificant amounts of the virus. Any test with a cycle threshold above...
By Apoorva Mandavilli | The New York Times |
Matthew Collin, Genomics Core Manager, left, and Assistant Professor Juliet Morrison

UCR virologist receives prestigious award from alma mater

Juliet Morrison, an assistant professor in UCR’s Department of Microbiology and Plant Pathology, has been honored by her alma mater, Bard College, with the John and Samuel Bard Award in Medicine and Science. The award honors scientists who demonstrate a breadth of concern and depth of commitment characterized by the pioneering father-and-son 18th century physicians...
By Imran Ghori | Inside UCR |

Gilead poised to upend market with its first Covid-19 study data

BLOOMBERG - Gilead Sciences Inc. , whose Covid-19 treatment has whipsawed markets amid conflicting early reports about its efficacy, is set to report the first results from a company-sponsored study of the experimental drug. Data from the first 400 severely ill coronavirus patients being treated with Remdesivir in an open-label study are expected before the...
By Cristin Flanagan | Bloomberg |
Let us help you with your search